Axon Enterprise, Inc. (NASDAQ:AXON) Stake Lowered by Victory Capital Management Inc.

Victory Capital Management Inc. reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 8.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,074 shares of the biotechnology company’s stock after selling 3,502 shares during the period. Victory Capital Management Inc.’s holdings in Axon Enterprise were worth $15,614,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of AXON. Blue Trust Inc. boosted its holdings in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Quent Capital LLC boosted its holdings in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares in the last quarter. Asset Dedication LLC bought a new stake in Axon Enterprise in the second quarter worth $47,000. Friedenthal Financial bought a new stake in Axon Enterprise in the third quarter worth $51,000. Finally, Cullen Frost Bankers Inc. bought a new stake in Axon Enterprise in the second quarter worth $59,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AXON. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Robert W. Baird increased their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Northland Securities increased their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Finally, Barclays increased their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $427.83.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 70,000 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $362.21, for a total value of $25,354,700.00. Following the transaction, the chief executive officer now directly owns 2,945,366 shares of the company’s stock, valued at approximately $1,066,841,018.86. This trade represents a 2.32 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 410,556 shares of company stock valued at $161,192,754. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $610.20 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $46.53 billion, a P/E ratio of 157.67, a P/E/G ratio of 15.05 and a beta of 0.94. The firm has a 50 day simple moving average of $448.52 and a 200 day simple moving average of $361.95. Axon Enterprise, Inc. has a fifty-two week low of $224.16 and a fifty-two week high of $624.84.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.